InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and proprietary treatments.
Insitu Biologics has raised $4.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2025.
Insitu Biologics's investors include Manhattan Street Fund.
Insitu Biologics is headquartered in Minnesota City, United States.
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and proprietary treatments.
Insitu Biologics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Insitu Biologics — Funding & Investors." VCBacked, December 18, 2025, https://www.vcbacked.co/company/insitu-biologics. Accessed August 16, 2026.
VCBacked. (2025). Insitu Biologics — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/insitu-biologics
{{cite web |title=Insitu Biologics — Funding & Investors |url=https://www.vcbacked.co/company/insitu-biologics |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated